SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-110633
Filing Date
2022-10-21
Accepted
2022-10-21 16:19:56
Documents
1
Group Members
DMITRY GENKINGEORGY TETSVICTOR TETS

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2228652d1_sc13g.htm SC 13G 68610
  Complete submission text file 0001104659-22-110633.txt   70313
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Subject) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89709 | Film No.: 221323965
SIC: 2834 Pharmaceutical Preparations

Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 646-617-3088
CLS Therapeutics, LLC (Filed by) CIK: 0001951493 (see all company filings)

IRS No.: 920236145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G